New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
05:58 EDTAZN, PStocks with implied volatility movement; P AZN
Stocks with implied volatility movement; Pandora (P) 58, AstraZeneca (AZN) 32 according to iVolatility.
News For P;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 14, 2014
16:21 EDTPOn The Fly: Closing Wrap
Subscribe for More Information
14:53 EDTAZNCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
12:58 EDTPOn The Fly: Midday Wrap
Subscribe for More Information
11:22 EDTPPandora rallies after CEO share purchase
The stock is being pushed higher by word that the CEO of the company made a purchase of 25,000 shares following the recent lows at $17.55. At the current price of $20.97 resistance is at the bottom of the bearish gap down in price from October 24th at $21.17. A move higher puts the shares back into the gap for a bullish gap fill. Resistance would be at $22.48 thereafter. Support is at $20.31. Approximately 10% of the float is short which is likely contributing to a squeeze higher.
11:05 EDTPPandora jumps following CEO share purchase
Shares of Pandora (P) are rallying after the company's CEO disclosed that he had bought 25,000 shares of the company's stock. WHAT'S NEW: In a regulatory filing last night, Pandora CEO Brian McAndrews disclosed that he had bought 25,000 of the company's shares on Wenesday at a price of $18.58 per share. McAndrews now owns over 475,000 shares of the stock, according to the filing. ANALYST REACTION: In a note to investors, Stifel analyst Scott Devitt wrote that McAndrews purchased the stock using his own personal funds. According to the analyst, it is quite rare for CEOs to take such an action. McAndrews' purchase of the stock was "a strong vote of confidence" in the company, Devitt contended. He kept a $29 price target and Buy rating on the shares. WHAT'S NOTABLE: Pandora announced that it would hold a conference call next Tuesday to discuss proceedings before the Copyright Royalty Board. The board will determine the company's new royalty structure by December 2015, Devitt wrote. PRICE ACTION: In mid-morning trading, Pandora climbed $2.30, or 12.5%, to $20.75.
09:38 EDTPActive equity options trading
Subscribe for More Information
08:18 EDTPPandora CEO share purchases a significant vote of confidence, says Stifel
Subscribe for More Information
07:14 EDTAZNAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
November 13, 2014
18:47 EDTPPandora to host conference call
Conference call to discuss the current Web IV proceeding before the Copyright Royalty Board will be held on November 18 at 5 pm.Webcast Link
18:40 EDTPOn The Fly: After Hours Movers
UP AFTER EARNINGS: TubeMogul (TUBE), up 12.4%... Weibo (WB), up 3.2%... Nordstrom (JWN), up 3.1%. ALSO HIGHER: Geron (GERN), up 30.7% after announcing a global strategic collaboration with Janssen Biotech... Baker Hughes (BHI), up 16.2% following reports that the company is in talks to be acquired by Halliburton (HAL)... Halliburton is up 1.4%... Pandora (P), up 4% after announcing a conference call to discuss Web IV proceeding... AmerisourceBergen (ABC), up 1.1% after being awarded a $4.06B government contract. DOWN AFTER EARNINGS: Retrophin (RTRX), down 6.6%... Phoenix New Media (FENG), down 8.4%... Voxeljet AG (VJET), down 8.6%... Intrexon (XON), down 1.1%... Youku Tudou (YOKU), down 5.7%... Applied Materials (AMAT), down 2.5%. ALSO LOWER: Puma Biotechnology (PBYI), down 6.9% following PB272 Phase II Trial results... EnLink Midstream (ENLK), down 4.8% after filing to sell 10.5M common units representing limited partners.
18:26 EDTPPandora announces conference call to discuss Web IV proceeding
Subscribe for More Information
07:16 EDTAZNBIT Congress to hold a conference
Subscribe for More Information
07:03 EDTAZNAstraZeneca initiates development program for Brilinta reversal agent
Subscribe for More Information
05:34 EDTAZNAstraZeneca, Isis Pharmaceuticals to co-develop oligonucleotide delivery methods
Subscribe for More Information
November 12, 2014
11:17 EDTAZNLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
07:48 EDTPWells Fargo to hold a conference
5th Annual Technology, Media & Telecom Conference is being held in New York on November 12-13.
07:35 EDTAZNAdvaxis submits IND application for ADXS-HPV Phase 1/2 study, MEDI4736
Advaxis (ADXS) announced that the company has submitted an Investigational New Drug application, or IND, to the FDA to conduct a Phase 1/2 study of ADXS-HPV alone or in combination with MedImmune's investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, for the treatment of advanced, recurrent or refractory human papillomavirus, or HPV,-associated cervical cancer and HPV-associated head and neck cancer. This follows the press release issued in July announcing the clinical trial collaboration between Advaxis and MedImmune, the global biologics research and development arm of AstraZeneca (AZN).
November 11, 2014
16:05 EDTAZNAmgen, AstraZeneca say Phase 3 brodalumab study met endpoints
Subscribe for More Information
15:43 EDTAZNLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
November 10, 2014
07:23 EDTPRBC Capital to hold a conference
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use